COVID -19: Glenmark Pharmaceuticals extends Min Rs. 10 Lakhs supports to deceased employees families
Glenmark Pharmaceuticals Ltd. (GPL), a global research-led pharmaceutical company extends support to deceased employees’ families who lost their lives battling with COVID-19.
Announcing the support company said, “It is deeply saddening to know that some of our colleagues who have battled or battling with COVID-19, and unfortunately some of them have lost their lives battling with this disease. Although no words could ever ease the pain of families of employees who have passed away. However, we want to reassure them of our unwavering support in these tough times.”
The company has announced to pay one year fixed salary (Minimum 10 lakhs to Max 1 crore) as a special benefit. This benefit is applicable to India-based full-time employees with retrospective effect and is being granted as a special benefit in addition to Group Life Term Insurance plans that are currently applicable.
The company said, “It will be the part of the employment term & conditions and will be subject to review in future.”
“While we can’t ever compensate for the loss suffered by the families, but hope that this benefit helps them rebuild their lives. We remain committed to the safety and wellbeing of our employees and their families, and urge them to continue taking utmost precautions to safeguard themselves.” the company added.
Glenmark Pharmaceuticals Ltd. (GPL) has its presence across Generics, Specialty and OTC business with operations in over 50 countries. Glenmark’s key therapy focus areas globally are respiratory, dermatology, and oncology. It is ranked among the top 80 Pharma & Biotech companies of the world in terms of revenue (SCRIP 100 Rankings published in the year 2019).
